CytomX Therapeutics CTMX
NASDAQ CTMX
$2.75 +0.06 (+2.23%)
At close: Sep 29, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Current Assets (2014 - 2026)

Updated

CytomX Therapeutics' Current Assets came in at $373.16 million for Q2 2026, up 126.7% from $164.62 million a year earlier and up 5.7% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) Current Assets (2014 - 2026) Analysis & Trends

At the end of FY2025, CytomX Therapeutics' Current Assets was $143.92 million, up 34.1% from FY2024.

  • Current Assets carries a five-year compound annual growth rate of -15.0% (FY2020 to FY2025).
  • Going back by year, Current Assets was $107.31 million in FY2024 (-41.3%), $182.94 million in FY2023 (-22.8%), $237.1 million in FY2022 (-23.6%) and $310.3 million in FY2021 (-4.2%).
  • The Q2 2026 figure represents the highest quarterly Current Assets since Q1 2021.
  • Year-over-year, Current Assets has increased for five consecutive quarters, with growth averaging 47.0% over the last eight quarters.
  • The fastest year-over-year change in Current Assets over five years came in Q1 2026 (growth of 307.6%), and the weakest in Q1 2025 (a decline of 48.2%).
  • Business Quant data shows CTMX's Current Assets at $353.1 million (Q1 2026), $143.92 million (Q4 2025) and $149.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 CytomX Therapeutics 586.15 Mn -371.52 Mn - 373.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 373.16 Mn
Mar 31, 2026 353.10 Mn
Dec 31, 2025 143.92 Mn
Sep 30, 2025 149.22 Mn
Jun 30, 2025 164.62 Mn
Mar 31, 2025 86.63 Mn
Dec 31, 2024 107.31 Mn
Sep 30, 2024 124.18 Mn
Jun 30, 2024 143.08 Mn
Mar 31, 2024 167.25 Mn
Dec 31, 2023 182.94 Mn
Sep 30, 2023 201.20 Mn
Jun 30, 2023 187.80 Mn
Mar 31, 2023 212.28 Mn
Dec 31, 2022 237.10 Mn
Sep 30, 2022 200.28 Mn
Jun 30, 2022 232.77 Mn
Mar 31, 2022 268.44 Mn
Dec 31, 2021 310.30 Mn
Sep 30, 2021 241.00 Mn
API Access

CytomX Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=CTMX&period=max&api_key=YOUR_API_KEY